Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003329 · ClinicalTrials.gov registry record
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
A clinical trial, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- 4,000
- Enrollment target
NCT00003329: Completed study, sponsored by Eastern Cooperative Oncology Group.
NCT00003329 is a clinical trial that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 4,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003329 has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
RATIONALE: Identification of genes that may be associated with developing certain types of cancer may someday provide important information about a person's risk of getting cancer. PURPOSE: This clinical trial is studying to see if certain genes may be associated with cancer in patients with cancer of the breast, prostate, lung, or colon and siblings of these patients.
Interventions
- GENETIC gene mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 1998-04-07 |
What the finished NCT00003329 record still lists
NCT00003329 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which gene mapping is the first listed.
NCT00003329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003329 about?
NCT00003329 is a clinical study titled "Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer". RATIONALE: Identification of genes that may be associated with developing certain types of cancer may someday provide important information about a person's risk of getting cancer. PURPOSE: This clinical trial is studying to see if certain genes may be associated with cancer in patients with cancer...
What is the current status of trial NCT00003329?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 1998-04-07.
What interventions are being tested in trial NCT00003329?
The interventions under investigation include: gene mapping (GENETIC).
Who is sponsoring clinical trial NCT00003329?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI